Double-Pronged Attack on Advanced Prostate Cancer Shows Promise

Scientists identify drug combination that can weaken prostate cancer cells

Double-pronged attack on advanced prostate cancer shows promise

Patients could one day be treated with the new combination of drugs.

Scientists discover drug combination to help prostate cancer patients live longer - The Mirror

The Institute of Cancer Research finds that combining existing breast and blood cancer drugs could halt the growth of tumours in the prostate

A combination of drugs could help treat up to 40% of patients in the late stages of advanced prostate cancer.

Scientists have found particular types of the disease could be vulnerable to this double-pronged attack. The drugs involved are already used to treat other cancers - and can help slow tumour growth and kill off cancer cells. Dr Adam Sharp, from The Institute of Cancer Research in Sutton, thinks this approach could be used more widely. https://audioboom.com/posts/8791587-dr-adam-sharpe-from-icr-sutton

Prostate Cancer Therapy Effectiveness Boosted by Combination with Enzyme Inhibition

An international study led by scientists at Flinders University and at South China University of Technology has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men. The preclinical in vitro and in vivo study found that two protein disulfide isomerase (PDI) enzymes—PDIA1 and PDIA5—are involved in androgen receptor (AR) regulation, and play a crucial role in help…

Scientists reveal new method that could treat patients with advanced prostate cancer – UK Times

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Scientists have found a new method that could treat patients with advanced prostate cancer. Experts at The Institute of Cancer Research, London, found that a two-pronged method could help treat as many as 40 per cent of patients with late-stage disease. Using drugs that are already being used…